ARTICLE | Clinical News
UT-15: Completed Phase III studies enrollment
November 15, 1999 8:00 AM UTC
United Therapeutics Corp. (UTHR), Silver Spring, Md. Product: UT-15 Business: Cardiovascular, Pulmonary Therapeutic category: Vasodilation Target: Pulmonary blood vessels Description: Synthetic non-i...